Aligos Therapeutics reported cash from operations of -$24.95M and free cash flow of -$24.95M for the quarter ended Jun 2026, down 60.9% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -33.12M | -37.71M | -35.62M | -19.92M | -18.62M | -21.89M | -22.95M | -18.79M | -18.04M | -27.89M | -34.86M | 5.06M | -19.26M | -82.15M | 43.09M | -15.86M | -31.54M | -14.55M | -23.04M | -1.50M | ||||||||
| Share-based CompensationStock Comp. | 5.64M | 3.65M | 9.24M | 9.01M | 10.08M | 3.42M | 10.79M | 10.51M | 11.13M | 2.58M | 10.13M | 10.04M | 2.04M | 1.71M | 1.01M | 1.16M | 1.68M | 1.46M | 2.11M | 2.14M | ||||||||
| Gains from Investment SecuritiesGains Investment | 14.37M | -30.48M | 0.10M | 62.13M | -61.49M | -1.68M | 4.21M | -1.21M | -3.40M | -2.98M | ||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.70M | |||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -25.37M | -37.48M | -20.43M | -25.04M | -17.14M | -16.78M | -22.39M | -13.62M | -20.34M | -22.66M | -22.75M | -19.49M | -20.10M | -18.40M | -20.91M | -15.50M | -24.34M | -21.75M | -23.13M | -24.95M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.19M | 0.28M | 0.31M | 0.32M | 0.37M | 0.38M | 0.39M | 0.36M | 0.37M | 0.38M | 0.39M | 0.54M | 0.47M | 0.37M | 0.32M | 0.72M | 0.71M | 0.44M | 0.51M | 0.47M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 1.12M | 0.40M | 0.74M | -0.99M | 0.17M | 1.81M | -1.92M | 0.42M | -0.30M | -0.42M | 0.33M | 3.98M | -4.08M | -0.17M | 1.73M | -0.40M | 0.75M | -0.67M | 3.66M | -1.21M | ||||||||
| Change in Accured ExpensesChange Accured Exp. | 4.00M | 3.88M | -6.07M | -6.35M | 0.90M | 2.39M | -0.94M | -1.26M | -1.46M | 4.58M | -4.80M | 0.02M | 2.10M | 1.29M | -4.76M | 1.41M | 1.40M | -0.08M | -1.54M | 6.71M | ||||||||
| Other Working Capital ChangesOther WC Changes | -1.54M | 12.06M | -3.62M | -1.98M | -0.57M | 0.57M | -2.09M | -2.17M | 0.78M | 1.18M | -0.20M | -0.14M | -0.17M | 0.30M | 0.15M | -0.34M | -0.59M | 0.68M | -0.32M | -0.62M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.10M | 0.34M | 0.52M | 0.33M | 0.00M | 0.09M | 0.01M | |||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 3.00M | 10.00M | 37.45M | 36.22M | 20.00M | 25.00M | 0.01M | 30.00M | 20.00M | 20.00M | 70.00M | 37.50M | 35.00M | 25.00M | ||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.04M | -16.48M | -60.40M | -9.98M | 32.48M | 11.60M | 19.99M | 25.00M | -0.01M | -0.01M | -88.64M | 39.99M | 10.40M | 19.97M | -44.07M | -39.42M | 47.68M | -2.02M | 34.93M | 25.00M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.02M | 0.01M | 0.10M | 0.09M | 0.02M | 0.44M | 0.09M | 0.14M | 0.12M | |||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 77.95M | 0.55M | -0.02M | 0.08M | -0.02M | 0.12M | -0.00M | 0.41M | -0.02M | 87.94M | -0.02M | 0.28M | -0.00M | 0.10M | 101.74M | -0.18M | -0.05M | 0.12M | -0.06M | 0.22M | ||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.48M | 3.64M | 5.09M | 1.52M | 2.25M | 2.89M | 0.36M | 0.41M | 1.16M | 0.44M | ||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||
| Change in Cash | 52.54M | -53.41M | -80.86M | -34.93M | 15.33M | -5.06M | -2.40M | 11.80M | -20.37M | 65.27M | -111.41M | 20.78M | -9.71M | 1.67M | 36.77M | -55.10M | 23.29M | -23.64M | 11.74M | 0.27M | ||||||||
| Free Cash FlowFCF | -25.46M | -37.82M | -20.95M | -25.37M | -17.14M | -16.87M | -22.39M | -13.62M | -20.34M | -22.66M | -22.75M | -19.49M | -20.10M | -18.40M | -20.91M | -15.50M | -24.34M | -21.75M | -23.13M | -24.95M | ||||||||
| Net Cash FlowNCF | 52.54M | -53.41M | -80.86M | -34.93M | 15.33M | -5.06M | -2.40M | 11.80M | -20.37M | 65.27M | -111.41M | 20.78M | -9.71M | 1.67M | 36.77M | -55.10M | 23.29M | -23.64M | 11.74M | 0.27M |